1. Search Result
Search Result
Results for "

IGFBP3

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Peptides

3

Natural
Products

6

Recombinant Proteins

1

Antibodies

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W074890
    Palmitoylglycine
    1 Publications Verification

    N-palmitoyl glycine

    Calcium Channel NO Synthase Neurological Disease Inflammation/Immunology
    Palmitoylglycine (N-palmitoyl glycine), an endogenous lipid that acts as a modulator of calcium influx and nitric oxide () production in sensory neurons. Palmitoylglycine is linked to an increased risk of Background Brugada syndrome (BrS) and interacts with BrS-associated proteins, demonstrating moderate binding affinities for DCC, CR1, CTSB, NAAA, DEFB1, EPHA1, IGF1/IGFBP3/ALS, and LTA [3].
    Palmitoylglycine
  • HY-RS06626

    Small Interfering RNA (siRNA) Others

    IGFBP3 Human Pre-designed siRNA Set A contains three designed siRNAs for IGFBP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    IGFBP3 Human Pre-designed siRNA Set A
    IGFBP3 Human Pre-designed siRNA Set A
  • HY-110135A
    NBI-31772 hydrate
    3 Publications Verification

    IGF-1R Neurological Disease
    NBI-31772 hydrate is a potent inhibitor of interaction between insulin-like growth factor (IGF) and IGF-binding proteins (IGFBPs). NBI-31772 hydrate is also a nonpeptide ligand that releases bioactive IGF-I from the IGF-I/IGFBP-3 complex (Kis=1-24 nM for all six human subtypes). Anxiolytic and antidepressant-like effects [3].
    NBI-31772 hydrate
  • HY-P10403

    IGF-1R Inflammation/Immunology Cancer
    IGFBP-3 peptide is a 18-amino acid insulin-like growth factor binding protein-3. IGFBP-3 peptide binds Humanin (HY-P1928) and Hyaluronan (HY-B0633A), blocks the interaction of CD44 and hyaluronan .
    IGFBP-3 peptide
  • HY-174650

    mRNA Metabolic Disease
    Human IGFBP3 mRNA encodes the human insulin like growth factor binding protein 3 (IGFBP3) protein, a member of the insulin-like growth factor binding protein (IGFBP) family. IGFBP3 can form a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors.
    Human IGFBP3 mRNA
  • HY-RS23885

    Small Interfering RNA (siRNA) Others

    Igfbp3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Igfbp3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Igfbp3 Rat Pre-designed siRNA Set A
    Igfbp3 Rat Pre-designed siRNA Set A
  • HY-RS17430

    Small Interfering RNA (siRNA) Others

    Igfbp3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Igfbp3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Igfbp3 Mouse Pre-designed siRNA Set A
    Igfbp3 Mouse Pre-designed siRNA Set A
  • HY-N3316
    Martynoside
    1 Publications Verification

    Others
    Martynoside protects ex vivo bone marrow cells from 5-fluorouracil (5-FU)-induced cell death and inflammation response by down-regulating the TNF signaling pathway .Martynoside is a potent antiestrogen in MCF-7 cells, increasing IGFBP3 levels
    Martynoside
  • HY-W074890R

    N-palmitoyl glycine (Standard)

    Reference Standards Calcium Channel NO Synthase Neurological Disease Inflammation/Immunology
    Palmitoylglycine (Standard) is the analytical standard of Palmitoylglycine. This product is intended for research and analytical applications. Palmitoylglycine (N-palmitoyl glycine), an endogenous lipid that acts as a modulator of calcium influx and nitric oxide () production in sensory neurons. Palmitoylglycine is linked to an increased risk of Background Brugada syndrome (BrS) and interacts with BrS-associated proteins, demonstrating moderate binding affinities for DCC, CR1, CTSB, NAAA, DEFB1, EPHA1, IGF1/IGFBP3/ALS, and LTA[1][2][3].
    Palmitoylglycine (Standard)
  • HY-182824

    Autophagy Others
    Sucrose dilaurate acts as an emulsifier, dispersant and stabilizer. Sucrose dilaurate reduces the release of HMGB1 from UVB-irradiated keratinocytes. Sucrose dilaurate inhibits melanogenesis and decreases bilirubin levels. Sucrose dilaurate induces autophagy in human epidermal keratinocytes, thereby reducing carboxymethyl lysine (CML) levels. Sucrose dilaurate reduces the secretion of insulin-like growth factor-binding protein 3 (IGFBP3) and nerve growth factor (NGF) by senescent keratinocytes. Sucrose dilaurate is investigated as an emulsifier, dispersant or stabilizer in the cosmetics, food and pharmaceutical industries [3] .
    Sucrose dilaurate

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: